ePosterDOI Available
The Fractal Geometry of Alzheimer’s disease Toward Better Cognitive Assessment
Tahmineh Azizi
Neuromatch 5 (2022)
Sep 28, 2022
Virtual (online)
Presentation
Sep 28, 2022
Event Information
Poster
View posterAbstract
Human brain is the most dynamic and varied system of the body. The brain is composed of neuron and
glia. But how do they interact to generate emergent properties like memory, learning, emotion and sleep
is little understood. Many such complex systems that exist in non-linear dynamics are characterized by
the fractal nature. The fractal dimension (FD) is a quantitative parameter that has been extensively used to
analyse the complexity of structural and functional patterns of the human brain. The fractal dimension (FD)
of the human brain quantifies the inherent complexity. Evidences strongly suggest that fractal properties
of a biologic system might be related to entropy and metabolism. In several pathologies of the brain such
as Alzheimer’s, Epilepsy and Stroke, fractal dimension (FD) is altered. FD in combination with other
features is emerging as a powerful diagnostic approach at the hands of a clinician. Alzheimer disease (AD)
is a progressive neurodegenerative disease that destroys memory and cognitive skills. Aging is the biggest
risk factor for AD. The central quest of research on AD is to identify the steps in its pathogenesis that,
if inhibited, would slow or prevent the disease. All AD patients develop neuritic plaques in brain areas
subserving memory and cognition. These plaques consist of extracellular masses of Aβ filaments intimately
associated with dystrophic dendrites and axons, activated microglia, and reactive astrocytes. In 1983, Benoit
Mandelbrot, the founder of fractal geometry, presented the amazing world of fractals to the world. Fractals
are infinitely complex objects which are self similar in different scales. In this study we are focused to
understand the changes in fractal properties (FD) of human brain as a whole in glioma during the states of
AD. A non-linear analysis called the Fractal Dimension (FD) has been performed to quantify the fractal
complexity of AD. Our primary goal is to investigate FD to assess whether it can discriminate between
different states of AD. From FD analysis, we noticed that the fractal dimension increases with aging the
AD, i.e. the complexity and self similarity of brain structure increases. We perform multi-fractal analysis to
discover whether AD and its states belong to class of multi-fractal object for which a large number of scaling
exponents are required to characterize their scaling structures. We plot the multi-fractal spectra of the fMRI
images to compare the width of the scaling exponent for each spectrum. According to our analysis, we have
a wide range of exponents for AD fMRI images, which indicates different states of Alzheimer’s disease
have multi-fractal structure. As a result, fractal geometry can be considered as a computational framework
to characterize different stages of AD and with further analysis, it can be used as a diagnostic tool to fight
against Alzheimer’s disease.